Valneva Soars as EU to Buy Up to 60 Million Covid Shots
- Rolling review by drug regulator seen starting soon: Valneva
- Shot adds to EU’s ‘broad portfolio’ of vaccines: Kyriakides
Valneva Covid-19 vaccine manufacture.
Source: Valneva SE
This article is for subscribers only.
Valneva SE shares soared after the European Commission agreed to buy as many as 60 million doses of the Covid-19 vaccine the French firm is developing.
The deal would allow EU member states to purchase almost 27 million doses from Valneva in 2022, and an additional 33 million in 2023, the commission said in a statement Wednesday. The shot has yet to be approved by the bloc’s medicines regulator.